March 10, 2020 / 12:59 PM / a month ago

BRIEF-Galera Therapeutics Reports Q4 Loss Per Share $1.31

March 10 (Reuters) - Galera Therapeutics Inc:

* GALERA THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS AND RECENT ACCOMPLISHMENTS

* Q4 LOSS PER SHARE $1.31

* Q4 EARNINGS PER SHARE ESTIMATE $-0.55 — REFINITIV IBES DATA

* GALERA THERAPEUTICS - AS OF DECEMBER 31, 2019, GALERA HAD CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS OF $112.3 MILLION

* GALERA THERAPEUTICS - EXPECTS CASH, CASH EQUIVALENTS & SHORT-TERM INVESTMENTS TO FUND OPERATING EXPENSES & CAPITAL EXPENDITURE REQUIREMENTS INTO 2022 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below